Welcome to a new episode of "WisBusiness: The Show," a twice-a-month Web show covering state business news and issues. This episode of “WisBusiness.com: The Show” features an interview with Rachel Neill of Carex Consulting Group and 1 Million Cups, who discusses Wisconsin’s startup scene. Tom Still...
MADISON, Wis., Aug. 1, 2017 /PRNewswire/ -- Moxe announced today the release of Convergence – a solution redefining the exchange of clinical information by integrating health plan member data and insights directly into clinician workflows at the point of care. Convergence is a conceptual shift providing automated, bi-directional exchange...
As a post-doctoral researcher at the University of Wisconsin-Madison, Bob Lindner used to develop artificial intelligence to better understand the stars, programming ways to analyze the data collected by massive telescopes. Now, his startup VEDA Data applies those same mechanics to something smaller in scale: the...
Invenra, a Madison startup involved in the race to find drugs that will beat cancer, says it is teaming with Merck, one of the world’s leading pharmaceutical companies. Invenra said it is collaborating with Merck to find the best antibodies for treating “an unnamed target of...
Exact Sciences Corp. gave a rosy report Tuesday on its finances for the second quarter of 2017, and said a major study on its second product in the pipeline — a test for lung cancer — will likely begin in early 2018. The Madison company, whose Cologuard...
A skin tissue product to treat serious burns — developed and manufactured in Madison — will get special attention from the FDA. StrataGraft is one of the first products to be designated as a “regenerative medicine advanced therapy” by the U.S. Food and Drug Administration. That...
Kiio, a Madison-based tech company with a health engagement platform, is partnering with the Department of Defense to test and develop a new protocol for treating -- and potentially avoiding -- a painful condition called tendinopathy. Tendinopathy is a term for a disease of the tendon,...
Today Kiio Inc. announced the enrollment of the first human subjects in the company’s $1.3 million multi-year, multi-institutional Department of Defense project to develop and validate a novel protocol to assist treatment and risk assessment for chronic tendinopathy. “Our goal is to provide a fast, cost-effective, portable protocol...
MADISON, Wis. - Amyotrophic lateral sclerosis, ALS, is a devastating disease with no known cure or effective treatments. A research project at UW-Madison is working to change that. “Our idea is to prevent the progression of the disease using the stem cells,” said Dr. Masatoshi Suzuki,...
The Wisconsin Economic Development Corporation has certified Varigen Biosciences as a Qualified New Business Venture (QNBV), the organization announced recently. According to a release, QNBV allows investors in Varigen Biosciences to receive a 25 percent state tax credit on the amount they invest in the business, up to $750,000...